← All organizations
Government of Italy
GovernmentWebsite ↗
Also known as: ASST Fatebenefratelli Sacco | Azienda Ospedaliera Fatebenefratelli e Oftalmico | Giuliano Rizzardini | Local Health Authority of Modena | Ministero della Salute, Italy | Ministero dell'Università e della Ricerca, Italia | Ministry of Education, Universities and Research, Italy | Ministry of Health, Italy | Public Health Service of South Tyrol, Italy
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2001Last known activity
Dec 31, 2025
Timeline
1940s
- Jan 1, 1946
Government of Italy— Founded
Drugs by trial phase (52 distinct, 29 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (23 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Arrhythmias, Cardiac
- Autism Spectrum Disorder
- Autistic Disorder
- Bone Diseases
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cataract
- Communicable Diseases
- Congenital Abnormalities
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Epilepsies, Partial
- Epilepsy
- Eye Infections
- Heart Failure
- HIV Infections
- Infections
- Inflammation
- Insulin Resistance
- Kidney Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Metabolic Syndrome
- Myelodysplastic Syndromes
- Osteoporosis
- Pneumococcal Infections
- Pneumonia
- Preleukemia
- Renal Insufficiency, Chronic
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Sarcoma
- Syndrome
- Thrombosis
- Vesico-Ureteral Reflux
Recent trials (38)
- NCT07176104CollaboratorN/ADec 31, 2025
- NCT06398054OfficialPhase 4Oct 1, 2024
- NCT06398054Sponsor investigatorPhase 4Oct 1, 2024
- NCT06398054Lead sponsorPhase 4Oct 1, 2024
- NCT06158698CollaboratorPhase 3Nov 14, 2023
- NCT05937490CollaboratorPhase 4Mar 27, 2023
- NCT05300672CollaboratorPhase 3Feb 8, 2022
- NCT05150704CollaboratorPhase 3Oct 7, 2021
- NCT04832880Lead sponsorPhase 3Apr 6, 2021
- NCT04832880Reponsible party - principal investigatorPhase 3Apr 6, 2021
- NCT04979468Overall official - principal investigatorPhase 3Mar 23, 2021
- NCT04646135CollaboratorPhase 2Dec 31, 2020
- NCT04646655Overall official - principal investigatorPhase 3Jul 27, 2020
- NCT04646655Lead sponsorPhase 3Jul 27, 2020
- NCT04646655Reponsible party - principal investigatorPhase 3Jul 27, 2020
Details
- Founded
- Rome, IT Jan 1, 1946
- Last known activity
- Dec 31, 2025